Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
349
mi
from
Dallas, TX
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
Click here to add this to my saved trials
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
583
mi
from
San Antonio, TX
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
5602
mi
from
Buenos Aires,
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
5602
mi
from
Buenos Aires,
Click here to add this to my saved trials
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Arkansas Specialty Orthopaedics & HipKneeArkansas Foundation for the Facility
369
mi
from
Little Rock, AR
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Arkansas Specialty Orthopaedics & HipKneeArkansas Foundation for the Facility
369
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
S.T.A.R. Orthopaedics, Inc.
1071
mi
from
La Quinta, CA
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
S.T.A.R. Orthopaedics, Inc.
1071
mi
from
La Quinta, CA
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Center for the Knee and Shoulder
1323
mi
from
Monterey, CA
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Center for the Knee and Shoulder
1323
mi
from
Monterey, CA
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Great Lakes Bone and Joint
736
mi
from
Battle Creek, MI
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Great Lakes Bone and Joint
736
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Orthopedic Associates of Pittsburgh
983
mi
from
Monroeville, PA
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Orthopedic Associates of Pittsburgh
983
mi
from
Monroeville, PA
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Advanced Orthopedics and Sports Medicine
550
mi
from
Cypress, TX
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Advanced Orthopedics and Sports Medicine
550
mi
from
Cypress, TX
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
JFK Medical Center
1289
mi
from
Atlantis, FL
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
JFK Medical Center
1289
mi
from
Atlantis, FL
Click here to add this to my saved trials
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated:  12/31/1969
Heekin Clinic
1055
mi
from
Jacksonville, FL
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
Status: Enrolling
Updated: 12/31/1969
Heekin Clinic
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty
Suture Fixation System Versus Tendonous Reconstruction in Thumb Carpometacarpal Arthroplasty: a Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Athens Orthopedic Clinic, PA
847
mi
from
Athens, GA
Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty
Suture Fixation System Versus Tendonous Reconstruction in Thumb Carpometacarpal Arthroplasty: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Athens Orthopedic Clinic, PA
847
mi
from
Athens, GA
Click here to add this to my saved trials
Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients
Phase 1 Trial of CII APL A12 in Rheumatoid Arthritis Patients
Status: Enrolling
Updated:  12/31/1969
Memphis VA Medical Center, Memphis, TN
470
mi
from
Memphis, TN
Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients
Phase 1 Trial of CII APL A12 in Rheumatoid Arthritis Patients
Status: Enrolling
Updated: 12/31/1969
Memphis VA Medical Center, Memphis, TN
470
mi
from
Memphis, TN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
643
mi
from
Indianapolis, IN
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1287
mi
from
Brooklyn, NY
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1287
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
683
mi
from
Birmingham, AL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
660
mi
from
Huntsville, AL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
660
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
844
mi
from
Paradise Valley, AZ
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
844
mi
from
Paradise Valley, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
856
mi
from
Peoria, AZ
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
856
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
843
mi
from
Scottsdale, AZ
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
843
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
349
mi
from
Hot Springs, AR
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
349
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
372
mi
from
Little Rock, AR
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1127
mi
from
Escondido, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1127
mi
from
Escondido, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1210
mi
from
Fresno, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1210
mi
from
Fresno, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1107
mi
from
Hemet, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1107
mi
from
Hemet, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1118
mi
from
La Jolla, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1118
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1133
mi
from
La Mesa, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1133
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1278
mi
from
Sacramento, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1278
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1178
mi
from
Torrance, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1178
mi
from
Torrance, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1152
mi
from
Tustin, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1152
mi
from
Tustin, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1135
mi
from
Upland, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1135
mi
from
Upland, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1125
mi
from
Wildomar, CA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1125
mi
from
Wildomar, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
383
mi
from
Colorado Springs, CO
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
383
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1317
mi
from
Danbury, CT
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1317
mi
from
Danbury, CT
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1229
mi
from
Lewes, DE
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1229
mi
from
Lewes, DE
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1314
mi
from
Aventura, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1314
mi
from
Aventura, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1292
mi
from
Boynton Beach, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1292
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1130
mi
from
Debary, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1130
mi
from
Debary, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1098
mi
from
Palm Harbor, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1098
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1110
mi
from
Pinellas Park, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1110
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1117
mi
from
Tampa, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1157
mi
from
Venice, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1157
mi
from
Venice, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1227
mi
from
Vero Beach, FL
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1227
mi
from
Vero Beach, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
805
mi
from
Decatur, GA
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
805
mi
from
Decatur, GA
Click here to add this to my saved trials